Longacting exenatide in diabetes: DURATION-3
- PMID: 20609957
- DOI: 10.1016/S0140-6736(10)60836-7
Longacting exenatide in diabetes: DURATION-3
Comment on
-
Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial.Lancet. 2010 Jun 26;375(9733):2234-43. doi: 10.1016/S0140-6736(10)60406-0. Lancet. 2010. PMID: 20609969 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
